These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Metabolism and pharmacokinetics of dibromodulcitol (DBD, NSC-104800) in man--II. pharmacokinetics of DBD. Horváth IP, Csetényi J, Hindy I, Kerpel-Fronius S, Institoris I, Hegedüs I, Eckhardt S. Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1211-9. PubMed ID: 6891658 [Abstract] [Full Text] [Related]
5. Toxicity, antitumour and haematological effects of 1,2-anhydro-6-bromogalactitol and d-mannitol: a comparison with the related dibromo- and dianhydro-derivatives. Horváth IP, Somfai-Relle S, Hegedüs L, Jarman M. Eur J Cancer Clin Oncol; 1982 Jun; 18(6):573-7. PubMed ID: 6811281 [Abstract] [Full Text] [Related]
8. The distribution of [3H]-dibromodulcitol in the central nervous system of patients with brain tumour. Csetényi J, Afra D, Kerpel-Fronius S, Horváth IP, Institoris L, Eckhardt S. Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1389-92. PubMed ID: 6685628 [Abstract] [Full Text] [Related]